Short answer
Eton Pharmaceuticals, Inc. (ETON) filed an 8-K current report with the SEC on June 9, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Jenn Adams and Charles J. Casamento elected to three-year director terms.
Eton Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Jenn Adams and Charles J. Casamento elected to three-year director terms
- Adams received 13,370,948 votes for versus 2,149,317 withheld
- Casamento received 9,925,548 votes for versus 5,594,717 withheld, signaling weaker shareholder support
- Grant Thornton LLP appointment ratified for fiscal 2026, with 16,942,328 votes for and 3,236,671 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Eton Pharmaceuticals, Inc. 8-K filings
Get the next ETON 8-K as it lands
Follow ETON for push alerts, or ask the research agent what this filing means.